Press release
Cancer Cachexia Market [2026-2033] | Anti-Cachexia Drugs, Appetite Stimulants, Emerging Drugs & Global Growth Expansion | Top 5 Companies 2026 - Aeterna Zentaris, Aphios Corporation, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology
Cancer Cachexia Market Size 2026
Download Free Updated Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/updated/cancer-cachexia-market?kb
United States: Recent Industry Developments
✅ March 2026: Pfizer Inc. advanced clinical research programs targeting cancer cachexia, focusing on anti-inflammatory and muscle-preserving therapies to improve patient outcomes.
✅ February 2026: Eli Lilly and Company expanded oncology supportive care pipeline, including investigational treatments addressing weight loss and metabolic dysfunction in cancer patients.
✅ January 2026: Bristol Myers Squibb strengthened collaborations with academic institutions to explore novel biomarkers for early detection and management of cancer cachexia.
✅ December 2025: Abbott Laboratories enhanced nutritional therapy solutions designed to support cancer patients suffering from cachexia and severe malnutrition.
Designed for industry leaders and decision-makers, this report offers actionable insights for strategic growth:- https://www.datamintelligence.com/partner-identification-enquiry/cancer-cachexia-market?kb
List of Key Players 2026:
Aeterna Zentaris, Aphios Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Helsinn Group, Merck KgaA, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology, Aavogen Inc.
Growth Forecast Projections 2026:
The Global Cancer Cachexia Market is projected to grow at a significant during the forecast period of 2026 to 2033. In 2025, the market is witnessing steady growth, and with increasing strategic initiatives adopted by key industry players, it is expected to continue upward trajectory throughout the forecast period.
Key Industry Developments 2025-2026:
✅ April 2026: Market players intensified research on multimodal therapies targeting inflammation, muscle wasting, and metabolic imbalance to improve patient outcomes and quality of life.
✅ March 2026: Pharmaceutical companies advanced late-stage clinical trials for novel cachexia treatments, focusing on appetite stimulation, weight stabilization, and preservation of lean muscle mass.
✅ February 2026: Increased collaborations between biotech firms and research institutions supported the development of targeted therapies addressing cytokine pathways and cancer-related metabolic dysfunction.
✅ January 2026: Integration of digital health tools and AI-driven monitoring solutions enhanced early diagnosis and personalized management of cachexia in oncology care.
✅ December 2025: Growing adoption of combination therapies, including nutritional support and pharmacological interventions, strengthened comprehensive cachexia management approaches.
✅ November 2025: Regulatory agencies and healthcare organizations emphasized guidelines for early intervention and standardized treatment protocols to address cancer-associated weight loss.
✅ October 2025: Rising investments in oncology supportive care and increased awareness among healthcare providers accelerated the adoption of cachexia treatment solutions.
How Our Market Research Process Works:
The global Cancer Cachexia Market research report is prepared using a robust combination of primary and secondary research sources. It offers a comprehensive analysis of key industry factors such as regulatory frameworks, evolving market dynamics, competitive landscape growth, and historical performance trends.The study further evaluates technological advancements, emerging innovations, and developments across adjacent industries. In addition, it examines market volatility, growth opportunities, potential barriers, and key challenges that may influence the long-term expansion of the Cancer Cachexia ecosystem.
Recent Mergers & Acquisitions (M & A) 2025-2026:
• Eli Lilly and Company announced acquisition of Kelonia Therapeutics for up to $7 billion (April 2026) to strengthen oncology pipeline including advanced cancer therapies
• Roquefort Therapeutics entered a £32 million reverse takeover to acquire oncology drug rights from Coiled Therapeutics (March 2026), expanding clinical-stage cancer treatment portfolio
Buy Now Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=cancer-cachexia-market?kb
Japan: Recent Industry Developments
✅ March 2026: Ono Pharmaceutical Co., Ltd. accelerated development of ghrelin receptor agonists aimed at improving appetite and body weight in cancer cachexia patients.
✅ February 2026: Eisai Co., Ltd. expanded oncology supportive care initiatives, focusing on integrated treatment approaches for cachexia management.
✅ January 2026: Takeda Pharmaceutical Company Limited increased R&D investment in metabolic disorder therapies linked to cancer-associated muscle wasting.
✅ December 2025: Kyowa Kirin Co., Ltd. explored biologic-based therapies targeting inflammation pathways associated with cancer cachexia progression.
Major Growth Key Segmentations 2026:
By Therapeutics: Corticosteroids, Cannabinoids (Dronabinol), Anabolic Steriods, Cytokine Inhibitors, Others
By Mechanism: Appetite Stimulators, Weight Loss Stabilizers, Others
By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacy
Regional Growth Analysis for Market:
⇥ North America: Leads the market with advanced healthcare infrastructure, strong oncology pipeline, and high awareness of cancer-associated weight loss management.
⇥ Asia-Pacific (including Japan): Rapidly expanding due to rising cancer prevalence, improving healthcare access, and increasing focus on supportive care treatments.
⇥ Europe: Growth driven by strong clinical research, government healthcare support, and increasing adoption of cachexia management therapies.
⇥ Middle East & Africa: Emerging market supported by improving oncology care infrastructure and gradual awareness of supportive cancer treatments.
We Provide Benefits of the Report:
Chapter 1: Establishes the report framework by defining scope, key market segments (region, product type, and application), and provides an overview of market size, growth outlook, and long-term industry trajectory.
Chapter 2: Highlights key market insights, focusing on major trends and transformative factors influencing the future direction of the industry.
Chapter 3: Examines the competitive landscape, including revenue share analysis, strategic developments, and significant mergers & acquisitions shaping market dynamics.
Chapter 4: Presents detailed profiles of leading companies, covering financial performance, product portfolios, profit margins, and key strategic milestones.
Chapters 5 & 6: Provide regional and country-level revenue analysis, outlining market size, growth drivers, and expansion opportunities across key geographies.
Chapter 7: Focuses on product type segmentation, identifying high-growth and opportunities within each segment.
Chapter 8: Analyzes application-based segmentation, evaluating demand across industries and highlighting key growth areas.
Chapter 9: Maps the complete supply chain structure, covering upstream and downstream activities to explain value creation across the ecosystem.
Chapter 10: Concludes with a summary of key findings, offering strategic insights and critical takeaways for stakeholders and decision-makers.
Get Report for Strategic Market Growth Customization: https://datamintelligence.com/customize/cancer-cachexia-market?kb
FAQ
Q1: What is the current size of the Cancer Cachexia Market Growth?
A: The Cancer Cachexia Market was valued at US$ 2.59 billion in 2025 and is forecasted to hit US$ 4.02 billion by 2033
Q2: How rapidly will the Market Is expanding?
A: The Cancer Cachexia market is projected to grow at a CAGR of 6.8% between 2026 and 2031.
Request Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Cachexia Market [2026-2033] | Anti-Cachexia Drugs, Appetite Stimulants, Emerging Drugs & Global Growth Expansion | Top 5 Companies 2026 - Aeterna Zentaris, Aphios Corporation, Artelo Biosciences Inc., NGM Biopharmaceuticals, Aveo Oncology here
News-ID: 4481386 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Instant Onigiri Market (2026-2033) | Japanese Cuisine Globalization & Asian Conv …
DataM Intelligence has released its latest research report, "Instant Onigiri Market Size 2026", offering a structured and data-driven assessment of evolving market dynamics and long-term growth potential. The study delivers detailed insights into market sizing, revenue trajectories, CAGR outlook, and regional performance trends, supported by robust segmentation analysis across key industry verticals. The report also highlights emerging growth pockets, investment-aligned opportunities, and areas where innovation and strategic expansion are reshaping…
Flying Cars Market Set to Record US$ 3,855.1 billion by 2035, Growth by surge To …
Market Growth & Size 206-2035
flying cars market reached US$ 5.7 billion in 2026 and is expected to reach US$ 3,855.1 billion by 2035, growing with a CAGR of 78.5% during the forecast period 2026-2035.
By 2029, EHang is expected to lead the market with a dominant 34.6% share, supported by its early-mover position in securing autonomous flight certifications and executing pilot trial programs across Asia and the Middle East.
Get Latest Sample…
Distance Health Technology Market to Reach USD 68.15 Billion by 2033 at 18.05% C …
The global distance health technology market was valued at USD 20.42 billion in 2025 and is projected to reach nearly USD 68.15 billion by 2033, growing at a CAGR of 18.05% during the forecast period from 2026 to 2033. The market is witnessing substantial growth driven by the increasing adoption of telehealth services, rising demand for remote patient monitoring solutions, and growing emphasis on improving healthcare accessibility across urban and…
Military Robotics Market Expected to Reach USD 34.82 Billion by 2032 Amid Rising …
The global Military Robotics Market is witnessing substantial growth as governments, defense agencies, military organizations, and aerospace manufacturers increasingly invest in autonomous systems, artificial intelligence-powered defense platforms, and next-generation battlefield technologies to strengthen operational efficiency, enhance national security capabilities, and modernize military infrastructure.
According to the latest market intelligence published by DataM Intelligence, the Global Military Robotics Market size reached US$ 21.52 billion in 2025 and is expected to reach US$…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
